These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5169739)

  • 1. [Relationship between urinary excretion of vanilmandelic acid (VMA) and clinical progress in 15 cases of neuroblastoma].
    Takada H; Inui A; Imashuku S; Kusunoki T; Sawada A
    Nihon Shonika Gakkai Zasshi; 1971 Oct; 75(10):917-23. PubMed ID: 5169739
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy].
    Lamedica G; Falcone R; De Bernardi B; Canini S
    Minerva Pediatr; 1978 Jan; 30(2):137-46. PubMed ID: 642879
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of urinary VMA determination in the neuroblastoma].
    Hanawa Y; Ise Y; Murakami T; Sakauchi N; Nagato T
    Nihon Shonika Gakkai Zasshi; 1970 Feb; 74(2):252-9. PubMed ID: 5461857
    [No Abstract]   [Full Text] [Related]  

  • 4. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
    Tuchman M; Ramnaraine ML; Woods WG; Krivit W
    Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
    Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
    Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
    Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of urinary 3-methoxy-4-hydroxymandelic acid (vanilmandelic acid) using thin-layer chromatography separation].
    Jarsumbeck B; Wendelin T; Hubl W
    Z Med Labortech; 1973; 14(5):259-68. PubMed ID: 4770624
    [No Abstract]   [Full Text] [Related]  

  • 8. The prognostic significance of vanillylmandellic acid in neuroblastoma.
    Aydin GB; Kutluk MT; Yalcin B; Varan A; Akyuz C; Buyukpamukcu M
    Pediatr Hematol Oncol; 2010 Sep; 27(6):435-48. PubMed ID: 20578806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of the determination of urinary catecholamines and urinary vanilmandelic acid in the diagnosis and control of neuroblastoma therapy].
    Rutiloni C; Serra GB
    Minerva Pediatr; 1968 Dec; 20(48):2481-7. PubMed ID: 5715834
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
    Horsmans Y; Desager JP; Harvengt C
    Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thin layer chromatography determination of 3-methoxy-4-hydroxymandelic acid in urine].
    Strobach H
    Z Klin Chem Klin Biochem; 1967 Mar; 5(2):77-9. PubMed ID: 5605212
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening procedures for neuroblastoma: false-negative results.
    Johnsonbaugh RE; Cahill R
    Pediatrics; 1975 Aug; 56(2):267-70. PubMed ID: 1161374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
    LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
    Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
    Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
    Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thin-layer chromatography of urinary homovanillic acid and vanillylmandelic acid for large-scale neuroblastoma mass screening.
    Auray-Blais C; Giguère R; Lemieux B
    Med Pediatr Oncol; 1989; 17(5):364-7. PubMed ID: 2796851
    [No Abstract]   [Full Text] [Related]  

  • 16. The VMA test strip: a new tool for mass screening, diagnosis, and management of catecholamine-secreting tumors.
    Leonard AS; Roback SA; Nesbit ME; Freier E
    J Pediatr Surg; 1972; 7(5):528-31. PubMed ID: 4673371
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative study of vanillylmandelic acid in random and 24-hour urine collections.
    Riddhimat R; Prabhant C; Sirisali K; Tangvarasithichai O; Poosiri A
    J Med Assoc Thai; 1990 May; 73(5):239-43. PubMed ID: 2212910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
    Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc oncogene and urinary catecholamines in children with neuroblastoma.
    Barontini M; Gutiérrez MI; Levin G; Mur N; Diez B
    Med Pediatr Oncol; 1993; 21(7):499-504. PubMed ID: 8341218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thin-layer chromatography for diagnosis of secreting neuroblastoma.
    Ebinger G; Verheyden R; Maurus R
    Eur J Pediatr; 1975 Dec; 121(1):63-9. PubMed ID: 1213038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.